Surgical prophylaxis in Belgian hospitals: estimate of costs and potential savings

The Journal of Antimicrobial Chemotherapy
A SasseG Verschraegen

Abstract

Between 1991 and 1995 the Belgian National Program for Surveillance of Hospital Infections (NSIH) collected data on perioperative antibiotic prophylaxis in 72 acute care hospitals. From the costs of prophylactic antibiotics for six categories of surgical procedure and from discharge summaries for hospitalization episodes nationwide, annual drug costs were estimated for 73% of Belgian surgical activity. Costs of antibiotics used in these surgical activities were estimated at 386-410 million Belgian francs (Bf) per year (US$12.1-12.9 million). After agreeing recommendations for best practice, the hypothetical costs of 'optimal' antimicrobial prophylaxis were calculated for the same selection of surgical procedures. It was calculated that savings of at least 194 million Bf (US$6.1 million) could be made if recommendations were followed closely. Only the costs borne by the National Health Insurance Institute for reimbursement of the dispensed drugs were considered in this study. Other direct costs, such as those related to drug storage, dispensing and administration, were not included.

Citations

Mar 9, 2004·The Journal of Hospital Infection·J-L QuenonUNKNOWN Agence Nationale d'Accréditation et d'Evaluation en Santé Working Group
Jun 30, 2000·Annales Françaises D'anesthèsie Et De Rèanimation·P Montravers
Jan 4, 2001·International Journal of Antimicrobial Agents·I C Gyssens
Jan 10, 2001·Current Opinion in Ophthalmology·T J Liesegang
Nov 23, 2012·The Australasian Medical Journal·Ru Shing Ng, Chee Ping Chong
May 25, 2012·American Journal of Infection Control·Cristiane SchmittRuth Natalia Teresa Turrini
Jul 9, 2005·The Journal of Hospital Infection·L WillemsG Laekeman
Apr 28, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Pierrick BedouchPatrice Francois
Jul 29, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mehrdad AskarianHarrison Weed
Jan 23, 2019·Current Opinion in Urology·Marco J SchnabelLaila Schneidewind
Apr 9, 2002·Journal of Chemotherapy·A S de BoerA J Mintjes-de Groot
Apr 4, 2021·International Urology and Nephrology·M J SchnabelP J Spachmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Mehrdad AskarianHarrison Weed
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
I C GyssensJ. A. A. Hoogkamp-Korstanje
© 2022 Meta ULC. All rights reserved